RxDoctor Payments DataLook up a doctor →

Andrew Bouley, MD

Neurology · Wellesley, MANPI 1831539519

Payments from drug & device makers

$1,607,976in general payments, 2019–2025

Across 395 payments — averaging $4070.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$752K
  • Novartis$377K
  • TG Therapeutics, Inc.$186K
  • EMD Serono, Inc.$140K
  • Biogen$80K
  • Genentech USA, Inc.$68K
  • plus $6K from 6 others
$29,966in research payments, 2019–2025

Across 12 payments — averaging $2497.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • TG Therapeutics, Inc.$26K
  • Novartis$3K
  • EMD Serono, Inc.$979

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.34$752,132
Novartis14$376,585
TG Therapeutics, Inc.71$185,623
EMD Serono, Inc.129$139,988
Biogen73$80,255
Genentech USA, Inc.54$67,676
Sanofi2$2,632
AstraZeneca3$1,396
Banner Life Sciences, LLC1$800
Amgen(2 entities)8$733
Bristol Myers Squibb4$124
E.r. Squibb & Sons, L.L.C.2$30

How this compares

$1,607,976 in reported general payments places this provider in the 95th percentile of 761 neurology providers in Massachusetts.

See all neurology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$1,361,560
Medicare patients
86
Services billed
28,407

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Wellesley

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →